logo image

HIV Molecular Immunology Database

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

QGTVSFSFPQITLWQRPL Pol(49-66) human epitope
-----lSFPQITLW---- Pol(49-66) escape documented in this paper; observed variant
      SFPQITLWQRPLVT Pol(55-68) B51, B52 human epitope
         QITLWQRPLVSIKVGGQI Pol(58-75) C*08:01 human epitope
         QITLWQRPLVSIKVGGQI Pol(58-75) C*12, C*14 human epitope
          ITLWQRPLV Pol(59-67) A*68:02, A*74:01, A19 human epitope
          ITLWQRPLV Pol(59-67) A2 human epitope
          ITLWQRPiV Pol(59-67) observed variant
          ITLWQRPfV Pol(59-67) observed variant
          ITLWQRPLV Pol(59-67) A2 transgenic mouse epitope
          ITLWQRPLV Pol(59-67) A28 human epitope
          ITLWQRPLV Pol(59-67) A28 human epitope
          ITLWQRPLV Pol(59-67) A28 supertype human epitope
          ITLWQRPLV Pol(59-67) A68 human epitope
          ITLWQRPLV Pol(59-67) A*68:02 human epitope
          ITLWQRPLV Pol(59-67) A*68:02 human epitope
          ITLWQRPLV Pol(59-67) A74 human epitope
          ITLWQRPLV Pol(59-67) A*74:01 human epitope
          ITLWQRPLV Pol(59-67) A*74:01 human epitope
          ITLWQRPLV Pol(59-67) B*35:02, B*35:03, B*53:01 human epitope
          ITLWQRPLV Pol(59-67) B*40 human epitope
          ITLWQRPLV Pol(59-67) C*04 human epitope
          ITLWQRPLV Pol(59-67) C*15 human epitope
          ITLWQRPLV Pol(59-67) C*17 human epitope
          ITLWQRPLV Pol(59-67) human epitope
          ITLWQRPIV Pol(59-67) human epitope
          ITLWQRPlV Pol(59-67) observed variant
          ITLWQRPLV Pol(59-67) human epitope
          ITLWQRPiV Pol(59-67) drug induced; observed variant
           TLWQRPLVTIR Pol(60-70) A*33:03 human epitope
            LWQRPLVTIKIGGQLKEA Pol(61-78) human epitope
             WQRPLVTI Pol(62-69) B*52:01 human epitope
             WQRPLViI Pol(62-69) escape documented in this paper; observed variant
             WQRPLVaI Pol(62-69) escape documented in this paper; observed variant
              QRPLVTIKI Pol(63-71) A*01:01 human epitope
              QRPiVTIKI Pol(63-71) drug induced; susceptible form
              QRPLVTVKIG Pol(63-72) B51 human epitope
              QRPiVTVKIG Pol(63-72) drug induced; escape documented in this paper
              QRPLVTVrIG Pol(63-72) HLA association; drug induced
               RPLVTIKI Pol(64-71) B*51 human epitope
               RPLVTIKI Pol(64-71) B*51 human epitope
                PLVTIKIGGQL Pol(65-75) B*67:01 human epitope
                  VTIKIGGQLK Pol(67-76) A*03:01 human epitope
                  VTIKIGGQLK Pol(67-76) A*11:01 human, humanized mouse, mouse epitope
                  VaIKIGGQLK Pol(67-76) non-susceptible form
                  VTIKIGGQLr Pol(67-76) susceptible form
                  VTvKIGGQLK Pol(67-76) susceptible form
                  VTIrIGGQLK Pol(67-76) susceptible form
                  VTIKvGGQLK Pol(67-76) susceptible form
                  VTIKIeGQLK Pol(67-76) non-susceptible form
                  VTIKIGGQiK Pol(67-76) susceptible form
                  VTvKIGGQLr Pol(67-76) susceptible form
                  VTvKIGGeLK Pol(67-76) non-susceptible form
                  VTvKIeGQLK Pol(67-76) non-susceptible form
                  VTvKvGGQLK Pol(67-76) susceptible form
                  VTvrIGGQLK Pol(67-76) susceptible form
                  VTIrIGGQLr Pol(67-76) susceptible form
                  VTIrvGGQLK Pol(67-76) susceptible form
                  VaIKIGGQiK Pol(67-76) susceptible form
                  VnIKvGGQLK Pol(67-76) non-susceptible form
                  VTIKIGGQir Pol(67-76) non-susceptible form
                  VTIKlGGQir Pol(67-76) susceptible form
                  VTvKIeGQLr Pol(67-76) non-susceptible form
                  VTvKvGGQLr Pol(67-76) susceptible form
                  VTIrvGGQLr Pol(67-76) susceptible form
                  VsIKvGGQiK Pol(67-76) susceptible form
                  VTvrvGGQLK Pol(67-76) susceptible form
                  VTIrvaGQvK Pol(67-76) non-susceptible form
                  VsIrvGGQtK Pol(67-76) non-susceptible form
                  VsIrvGGQiK Pol(67-76) non-susceptible form
                  VsIKvGGQir Pol(67-76) non-susceptible form
                  VTvrIGGmqK Pol(67-76) non-susceptible form
                  VsIrvGGQtr Pol(67-76) non-susceptible form
                  iTvKIGkevr Pol(67-76) non-susceptible form
                  VTIKIGGQLK Pol(67-76) A3 human epitope
                  VTILIGGQLK Pol(67-76) A3 supertype human epitope
                  VTIKIGGQLK Pol(67-76) A3 supertype human, mouse epitope
                   TIKIGGQLK Pol(68-76) A3 supertype human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo